Pulmonary Embolism Thrombolysis Selection

Classify PE as high risk when there is hemodynamic instability. The AHA framework defines massive PE as systolic blood pressure below 90 mm Hg for more than 15 minutes or a requirement for inotropic support. In this group, systemic thrombolysis is the established reperfusion strategy when there is no prohibitive bleeding risk. BMJ+2BMJPulmonary embolism - Symptoms, diagnosis and treatment | BMJ Best Practice USjacc2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM ... - JACCjaccEfficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism

A normotensive patient is not automatically low risk. Obtain a validated clinical severity score such as PESI or sPESI, assess RV function by echocardiography or CT, and measure troponin. An elevated PESI or sPESI combined with both RV dysfunction and elevated troponin identifies intermediate-high-risk PE; an elevated score with neither or only one positive RV injury marker is intermediate-low risk. BMJ+2BMJManagement dilemmas in acute pulmonary embolism - Thoraxjacc2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM ... - JACCScienceDirectIntermediate-high risk pulmonary embolism: When teamwork really ...

For intermediate-high-risk PE, begin systemic anticoagulation and monitor for hemodynamic deterioration rather than giving routine up-front systemic thrombolysis. The key operational distinction is that thrombolysis becomes a rescue or individualized escalation decision in a normotensive patient, but an immediate reperfusion decision in high-risk PE. NEJM+3NEJMCatheter-Directed Thrombolysis for Intermediate- and High-Risk Pulmonary Embolism | NEJM ClinicianBMJPulmonary embolism - Symptoms, diagnosis and treatment | BMJ Best Practice USScienceDirectIntermediate-high risk pulmonary embolism: When teamwork really ...Oxford AcademicEndovascular management of intermediate-risk pulmonary embolism

Systemic thrombolysis rapidly improves RV function and hemodynamic parameters and is recommended for high-risk PE. In a patient with shock or sustained hypotension, do not wait for a progressive biomarker profile before evaluating contraindications and delivering reperfusion therapy. BMJ+2BMJPulmonary embolism - Symptoms, diagnosis and treatment | BMJ Best Practice USjaccEfficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary EmbolismOxford AcademicUltrasound-assisted thrombolysis for acute pulmonary embolism

For normotensive intermediate-risk PE, systemic thrombolysis can reduce death or hemodynamic deterioration, but bleeding limits routine use. In PEITHO, tenecteplase was associated with major bleeding in 6.3% and intracranial hemorrhage in 2.0%, versus 1.5% and 0.2%, respectively, with heparin alone. BMJ+1BMJManagement dilemmas in acute pulmonary embolism - ThoraxNatureMortality and bleeding associated with the management of sub-massive pulmonary embolism: a systematic review and Bayesian network meta-analysis | Scientific Reports

The bleeding signal is consistent across broader comparative evidence. Compared with anticoagulation alone, systemic thrombolysis was associated with higher major bleeding (odds ratio 2.16) and intracranial hemorrhage (odds ratio 2.26), without a mortality difference in a meta-analysis including 81,705 patients. These findings support avoiding routine lysis in stable intermediate-risk patients even when RV dysfunction is present. jaccjaccEfficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism

Use systemic thrombolysis as rescue therapy when a patient initially managed as intermediate-high risk develops hemodynamic decompensation, provided bleeding risk is acceptable. Escalate the decision through a multidisciplinary PE team when available, particularly if rescue lysis, catheter-directed therapy, surgical embolectomy, or mechanical circulatory support may be needed. jacc+2jaccInnovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism | JACC: Cardiovascular InterventionsScienceDirectIntermediate-high risk pulmonary embolism: When teamwork really ...ScienceDirectInnovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism

Consider catheter-directed therapy (CDT) when a patient with high-risk PE needs reperfusion but systemic thrombolysis is contraindicated or has failed. CDT is also used in selected intermediate-high-risk patients with hemodynamic decompensation or substantial risk for deterioration when bleeding risk makes systemic thrombolysis unattractive. jacc+1jaccInnovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism | JACC: Cardiovascular InterventionsScienceDirectInnovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism

Catheter-directed thrombolysis uses less than one quarter of the systemic thrombolytic dose, offering a rationale for reduced systemic exposure. However, device-specific selection should not be based on an assumption of proven superiority: randomized comparative evidence against anticoagulation or systemic thrombolysis remains limited. NEJM+1NEJMCatheter-Directed Thrombolysis for Intermediate- and High-Risk Pulmonary Embolism | NEJM ClinicianScienceDirectInnovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism

Comparative pooled data are hypothesis-supporting but not definitive. In a meta-analysis of 45 studies, CDT versus anticoagulation was associated with lower mortality (odds ratio 0.55) but higher major bleeding (odds ratio 1.84); systemic thrombolysis had higher mortality and intracranial hemorrhage than CDT in that analysis. Observational study contribution and mixing of intermediate- and high-risk populations limit direct treatment ranking. NEJM+1NEJMCatheter-Directed Thrombolysis for Intermediate- and High-Risk Pulmonary Embolism | NEJM ClinicianjaccEfficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism

Use surgical embolectomy when fibrinolysis is contraindicated or unsuccessful, especially when immediate mechanical reperfusion is required. Mechanical circulatory support may be part of the strategy for life-threatening high-risk PE, but selection should occur in a center able to coordinate interventional, surgical, and critical care capabilities. ScienceDirect+2ScienceDirectIntermediate-high risk pulmonary embolism: When teamwork really ...ScienceDirectInnovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary EmbolismWileyComparison of interventions for intermediate to high‐risk pulmonary ...

Admit intermediate-high-risk patients to a setting that permits frequent blood-pressure and perfusion reassessment. Repeat clinical evaluation promptly for hypotension, shock, or a need for inotropic support, because these findings reclassify the patient into a high-risk pathway and trigger immediate reassessment for reperfusion. jacc+1jacc2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM ... - JACCScienceDirectIntermediate-high risk pulmonary embolism: When teamwork really ...

Use the initial RV imaging and troponin results for risk designation, not as isolated indications for lysis. Echocardiography, CT, and cardiac biomarkers add prognostic discrimination to PESI or sPESI; patients designated low risk by clinical score but with RV dysfunction on echocardiography or CT have higher odds of all-cause mortality in pooled data. BMJ+1BMJManagement dilemmas in acute pulmonary embolism - Thoraxjacc2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM ... - JACC

For a stable patient with RV dysfunction and elevated troponin, reassess bleeding risk before any rescue intervention. The benefit of preventing deterioration must be weighed against the excess intracranial hemorrhage and major bleeding observed with systemic thrombolysis in intermediate-risk PE. BMJ+2BMJManagement dilemmas in acute pulmonary embolism - ThoraxNatureMortality and bleeding associated with the management of sub-massive pulmonary embolism: a systematic review and Bayesian network meta-analysis | Scientific ReportsjaccEfficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism